BridgeBio Pharma, Inc. Non-current Liabilities (Other)

Non-current Liabilities (Other) of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-current Liabilities (Other) growth rates and interactive chart.


Highlights and Quick Summary

  • Non-current Liabilities (Other) for the quarter ending September 30, 2022 was $28.2 Million (a -1.41% decrease compared to previous quarter)
  • Year-over-year quarterly Non-current Liabilities (Other) increased by 27.9%
  • Annual Non-current Liabilities (Other) for 2021 was $22.1 Million (a 131.82% increase from previous year)
  • Annual Non-current Liabilities (Other) for 2020 was $9.52 Million (a 169.92% increase from previous year)
  • Annual Non-current Liabilities (Other) for 2019 was $3.53 Million (a 612.53% increase from previous year)
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-current Liabilities (Other) of BridgeBio Pharma, Inc.

Most recent Non-current Liabilities (Other)of BBIO including historical data for past 10 years.

Interactive Chart of Non-current Liabilities (Other) of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. Non-current Liabilities (Other) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $28.23 $28.63 $26.83
2021 $22.07 $27.58 $13.27 $11.61 $22.07
2020 $9.52 $13.47 $9.4 $2.8 $9.52
2019 $3.53 $1.39 $3.53
2018 $0.62 $0.5
2017 $0.0

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology